Amyotrophic Lateral Sclerosis (ALS) Model

Transgenic SOD1 (superoxide dismutase 1) mice express a G93A mutant form of human SOD1. SOD1 mice (TgN-SOD1-G93A-1Gur) exhibit a phenotype similar to amyotrophic lateral sclerosis (ALS) in humans, an age-related rapidly progressive decline of motor functions accompanied by degenerative changes of motoneurons within the spinal cord, brain stem and neocortex.

Charles River has obtained the license from Northwestern University/Harvard/MIT to utilize this transgenic model for contract efficacy studies. All characterization and analytical methods used with the model are performed in our proprietary labs by our own staff of scientists and technicians.

  • Body weight
  • Kaplan-Meyer survival plot
  • Motor deficits
    • Rotarod
    • Grip strength
    • Clinical scoring for disease state
    • Open field test
      • Distance traveled
      • Rearing frequency
  • MRI for neurodegeneration in the brain stem
  • MRS for metabolic changes in the brain stem
  • Motor neuron counts

You may also be interested in...

technician in safety goggles pipetting under laboratory fume hood

In Vitro ALS Model

Primary cultures offer fast access to study molecules of interest directly in relevant cell types. Primary cultures are real cells present in tissue instead of immortalized cell lines and are good tools for lead molecule identification.

Biomarker Services

We can support your drug discovery pipeline by providing biomarker analysis in a non-GxP environment.

Eureka: The Ultimate Ice Bucket Challenge

The ice bucket challenge has helped raise awareness and millions of dollars for ALS research. The bigger challenge will be finding more effective treatments, a cure or a way to prevent this complex neurodegenerative disorder.

Imaging Services

Imaging Services

Our range of imaging modalities can dramatically increase the efficiency and significantly enhance the value of your in vivo study.